Familial aggregation and antimicrobial response dose-dependently affect the risk for Crohn's disease

Inflammatory Bowel Diseases

Volumn 16, Issue 1, 2010, Pages 58-67

  Joossens, Marie ^a   Van Steen, Kristel ^b   Branche, Julien ^c   Sendid, Boualem ^d   Rutgeerts, Paul ^a   Vasseur, Francis ^e   Poulain, Daniel ^d   Broly, Franck ^f   Colombel, Jean Frédéric ^c   Vermeire, Séverine ^a   Chamaillard, Mathias ^c  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c UNIV LILLE   (France)

^d INSERM   (France)

^e EPIMAD   (France)

^f France Institut Pasteur de Lille   (France)

Author keywords

Antimicrobial antibodies; Disease prediction; Familial aggregation; IBD incidence; NOD2

Indexed keywords

ANTIBODY; BACTERIAL ANTIGEN; BACTERIAL FLAGELLUM ANTIBODY; BACTERIAL SEQUENCE I2 ANTIBODY; BACTERIUM ANTIBODY; CARD8 PROTEIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CHITOBIOSIDE CARBOHYDRATE ANTIBODY; FUNGUS ANTIBODY; LAMINARIBIOSIDE CARBOHYDRATE ANTIBODY; OUTER MEMBRANE PROTEIN C; OUTER MEMBRANE PROTEIN C ANTIBODY; PROTEIN; PROTEIN ANTIBODY; SYNTHETIC MANNOSIDE ANTIBODY; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ADULT; ANTIBODY RESPONSE; ARTICLE; BELGIUM; CANDIDA ALBICANS; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; ENVIRONMENTAL FACTOR; FAMILY; FEMALE; FOLLOW UP; FRANCE; GENE MUTATION; GENETIC RISK; HIGH RISK POPULATION; HUMAN; INCIDENCE; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; MICROBIAL IMMUNITY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELATIVE; RISK ASSESSMENT; SACCHAROMYCES CEREVISIAE; SEROLOGY;

ADULT; ANTIGENS, BACTERIAL; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CROHN DISEASE; FAMILY; FEMALE; FOLLOW-UP STUDIES; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOGLOBULIN G; MALE; PEDIGREE; PROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 74049121872     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20985     Document Type: Article

References (36)

1. Russell RK, Satsangi J. IBD: a family affair. Best Pract Res Clin Gastroenterol. 2004;18:525-539.
2. Monsen U, Bernell O, Johansson C, et al. Prevalence of inflammatory bowel disease among relatives of patients with Crohn's disease. Scand J Gastroenterol. 1991;26:302-306.
3. Probert CSJ, Jayanthi V, Hughes AO, et al. Prevalence and family risk of ulcerative colitis and Crohn's disease - an epidemiologic study among Europeans and South Asians in Leicestershire. Gut. 1993;34:1547-1551.
4. Orholm M, Munkholm P, Langholz E, et al. Familial occurrence of inflammatory bowel disease. N Engl J Med. 1991;324:84-88.
5. Peeters M, Nevens H, Baert F, et al. Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology. 1996;111:597-603.
6. Yang H, Mcelree C, Roth MP, et al. Familial empirical risks for inflammatory bowel disease - differences between Jews and non-Jews. Gut. 1993;34:517-524.
7. Freeman HJ. Familial Crohn's disease in single or multiple first-degree relatives. J Clin Gastroenterol. 2002;35:9-13.
8. Satsangi J, Grootscholten C, Holt H, et al. Clinical patterns of familial inflammatory bowel disease. Gut. 1996;38:738-741.
9. Gower Rousseau C, Grandbastien B, Cortot A, et al. Epidemiology of inflammatory bowel disease: is there a "Belgian-French exception?" Acta Gastroenterol Belg. 1996;59:2.
10. Van Kruiningen HJ, Joossens M, Vermeire S, et al. Environmental factors in familial Crohn's disease in Belgium. Inflamm Bowel Dis. 2005;11:360-365.
11. Comes MC, Gower Rousseau C, Colombel JF, et al. Inflammatory bowel disease in married-couples - 10 cases in Nord-Pas-De-Calais region of France and Liege County of Belgium. Gut. 1994;35:1316-1318.
12. Laharie D, Debeugny S, Peeters M, et al. Inflammatory bowel disease in spouses and their offspring. Gastroenterology. 2001;120:816-819.
13. Bennett RA, Rubin PH, Present DH. Frequency of inflammatory bowel disease in offspring of couples both presenting with inflammatory bowel disease. Gastroenterology. 1991;100:1638-1643.
14. Colombel JF, Grandbastien B, Gower Rousseau C, et al. Clinical characteristics of Crohn's disease in 72 families. Gastroenterology. 1996; 111:604-607.
15. Polito JM, Childs B, Mellits ED, et al. Crohn's disease: Influence of age at diagnosis on site and clinical type of disease. Gastroenterology. 1996;111:580-586.
16. Polito JMII, Rees RC, Childs B, et al. Preliminary evidence for genetic anticipation in Crohn's disease. Lancet. 1996;347:798-800.
17. Grandbastien B, Peeters M, Franchimont D, et al. Anticipation in familial Crohn's disease. Gut. 1998;42:170-174.
18. Hopper JL, Bishop DT, Easton DF. Genetic epidemiology 6 - population-based family studies in genetic epidemiology. Lancet. 2005;366:1397-1406.
19. Economou M, Trikalinos TA, Loizou KT, et al. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol. 2004;99:2393-2404.
20. Sendid B, Colombel JF, Jacquinot PM, et al. Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diagn Lab Immunol. 1996;3:219-226.
21. Peeters M, Vermeire S, Joossens S, et al. Diagnostic value of ASCA (anti-saccharomyces cerevisae antibodies) and pANCA (perinuclear antineutrophil cytoplasmic antibodies) in inflammatory bowel disease. Gastroenterology. 2000;118:A105.
22. Ferrante M, Henckaerts L, Joossens M, et al. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut. 2007;56:1394-1403.
23. Israeli E, Grotto I, Gilburd B, et al. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut. 2005;54:1232-1236.
24. Mow WS, Vasiliauskas EA, Lin YC, et al. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology. 2004;126:414-424.
25. Targan SR, Landers CJ, Yang HY, et al. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology. 2005;128:2020-2028.
26. Dubinsky MC, Taylor K, Targan SR, et al. Immunogenetic phenotypes in inflammatory bowel disease. World J Gastroenterol. 2006;12:3645-3650.
27. Bayless TM, Tokayer AZ, Polito JM, et al. Crohn's disease: Concordance for site and clinical type in affected family members - potential hereditary influences. Gastroenterology. 1996;111:573-579.
28. Standaert-Vitse A, Chamaillard M, Joossens M, et al. Candida Albicans carriage and Asca in familial Crohn's disease. Am J Gastroenterol. (in press).
29. Khoury PVE, Colombel JF, Joossens S, et al. Detection of antisynthetic mannoside antibodies (A Sigma MA) reveals heterogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and prediction. Am J Gastroenterol. 2008;103:949-957.
30. Langholz B, Ziogas A, Thomas DC, et al. Ascertainment bias in rate ratio estimation from case-sibling control studies of variable age-at-onset diseases. Biometrics. 1999;55:1129-1136.
31. Abecasis GR, Cherny SS, Cookson WO, et al. Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet. 2002;30:97-101.
32. Epi info (FBAT/PBAT). http://biosun1.harvard.edu/~fbat/fbat.htm 2008.
33. Martin ER, Ritchie MD, Hahn L, et al. A novel method to identify gene-gene effects in nuclear families: The MDR-PDT. Genet Epidemiol. 2006;30:111-123.
34. Epi info (S.A.G.E. 2008). Statistical Analysis for Genetic Epidemiology. http://darwin.cwru.edu/2008.
35. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York: John Wiley & Sons; 1987.
36. Shivananda S, Lennard Jones J, Logan R, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European collaborative study on inflammatory bowel disease (EC-IBD). Gut. 1996;39:690-697.